Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents
Status:
Not yet recruiting
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of three low-concentration atropine sulfate eye drops
(0.01%, 0.025% and 0.05%) in controlling the progression of myopia in Chinese children and
adolescents through a two-year clinical trial.
Phase:
N/A
Details
Lead Sponsor:
Shanghai Eye Disease Prevention and Treatment Center
Collaborators:
Peking University People's Hospital Shandong University of Traditional Chinese Medicine Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine